You reviewed .... for this content
out of 5
5...
4...
3...
2...
1...
Event : ESC Congress 2016
Topic : Other
Nurse-led telephone-based follow-up of secondary prevention after acute myocardial infarction: one-year results from the randomized controlled NAILED-ACS trial.
Six sigma approach to reduce door-to-balloon time for patients with ST-elevation myocardial infarction undergoing primary PCI
Evolution of European Society of Cardiology Guidelines since 2000: a systematic appraisal
Inhibition of acetylcholinesterase by bromide pyridostigmine prevents ventricular dysfunction, autonomic and reduce inflammatory profile in rats treated previously to myocardial infarction
Antihypertensive and anti-inflammatory effects of pentoxifylline? A Systematic review and meta-analysis of randomized controlled trials
The treatment benefit of the ACE-inhibitor perindopril on top of beta-blocker therapy in patients with vascular disease
Healthcare use in peripheral arterial disease without history of stroke/TIA in a large health organization
Evaluation of effectiveness of a dedicated educative movie on understanding and satisfaction of patients before coronary angiography: the INFOCORO study
Randomized controlled dietary intervention trial comparing mediterranean and vegetarian diets for cardiovascular prevention: preliminary results
Long-term treatment with atorvastatin does not improve diastolic function compared with placebo in hypertensive patients in the Anglo Scandinavian cardiac outcome trial (ASCOT)
A systematic review and meta-analysis of randomized controlled trials investigating the effects of statin therapy on plasma lipid concentrations in hiv-infected patients.
Adverse events in patients with LDL-C <0.65 mmol/L (<25 mg/dL) or <0.39 mmol/L (<15 mg/dL) during alirocumab treatment for up to 104 weeks: data from 14 randomized trials
Efficacy of evolocumab in patients across ESC/EAS CV risk subgroups
Comparative renal safety of rosuvastatin versus other statins in patients with very high cardiovascular risk
Effects of angiotensin converting enzyme inhibition or angiotensin receptor blockade in dialysis patients: a nation-wide data survey and propensity analysis
Long-term safety, tolerability, and efficacy of evolocumab in patients with heterozygous familial hypercholesterolaemia
Pharmacokinetics and pharmacodynamics of evolocumab in patients with renal impairment
Comparison of efficacy and safety of rosuvastatin 15 mg vs. 10 mg: subanalysis of the ROSU-PATH trial
Evaluation of target LDL-C levels attainment in patients at different cardiovascular risk: analysis of the ROSU-PATH trial
LDL extracellular vesicle coagulation protein levels change after initiation of statin therapy in healthy individuals
Get your access to resources
Our mission: To reduce the burden of cardiovascular disease
